Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
CagriSema achieved 22.7% at 68 weeks while tirzepatide achieved 22.5% at 72 weeks
Our team strongly advises against this practice
Whether youre dealing with patellar tendonitis, ACL/MCL strains, osteoarthritis, or chronic inflammation, our providers develop personalized treatment plans tailored to your specific injury and goals
Use them as intended
The FDA approved semaglutide for chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition like hypertension, high cholesterol, or type 2 diabetes
Get a personalized treatment plan with medication
US$ 22.12
US$ 27.91
US$ 29.50
US$ 21.86
